Novartis AG (NVSEF)
96.46
+0.14
(+0.14%)
USD |
OTCM |
Jan 06, 16:00
Novartis Shareholders Equity (Quarterly): 43.32B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AC Immune SA | 154.72M |
| CRISPR Therapeutics AG | 1.940B |
| Addex Therapeutics Ltd | 13.15M |
| NLS Pharmaceutics Ltd | -9.268M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 103.52B |
| Total Liabilities (Quarterly) | 60.08B |
| Debt to Equity Ratio | 0.6999 |
| Current Ratio | 1.111 |
| Net Debt Paydown Yield | -0.34% |